Previous Close | 0.0800 |
Open | 0.0800 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0750 - 0.0831 |
52 Week Range | 0.0550 - 0.6520 |
Volume | |
Avg. Volume | 38,560 |
Market Cap | 28.032M |
Beta (5Y Monthly) | -0.60 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0350 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for MVMDF
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to provide a business update on its technologies and key initiatives. KEY TECHNOLOGIES: MVMD’s primary technologies are being developed with the objective to improve the administration, efficacy and safety of new and existing medicines, therapies, and nutraceuticals. The Company’s Quicksome™ desiccation technology utilizes advanced liposomal tec
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Dr. Elizabeth Norton to an advisory position to support MVMD’s key Quicksome™ vaccine and cold chain projects. Dr. Norton is an immunologist with 20 years of experience in evaluating immunity, vaccines, and microbial infections. She has a public health and research background with a current faculty appointment in t
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) announces the adoption of a restricted share unit plan (the "RSU Plan"), a grant of restricted share units pursuant to the RSU Plan (each, an "RSU") and the grant of stock options pursuant to its existing stock option plan (the “Stock Option Plan”). “We continue to leverage option and share-based compensation levers in an effort to fully align our team’s ef